Cargando…
Psoas abscess during treatment with intravenous tocilizumab in a patient with rheumatoid arthritis: a case-based review
Interleukin-6 receptor antagonist tocilizumab is a biologic drug used for treating patients with active rheumatoid arthritis (RA) who failed to respond to synthetic or other biologic disease-modifying antirheumatic drugs or where they were contraindicated. Interleukin-6 receptor blockade results in...
Autores principales: | Vajdić, Ines Doko, Štimac, Goran, Pezelj, Ivan, Mustapić, Matej, Grazio, Simeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880036/ https://www.ncbi.nlm.nih.gov/pubmed/33576887 http://dx.doi.org/10.1007/s00296-021-04800-y |
Ejemplares similares
-
Psoas and Mediastinal Abscesses during Intravenous Tocilizumab Treatment in Multicentric Castleman Disease
por: Togitani, Kazuto, et al.
Publicado: (2022) -
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
por: Cai, Shaozhe, et al.
Publicado: (2020) -
Agranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritis
por: Giraud, C., et al.
Publicado: (2016) -
Psoas Abscess
Publicado: (1908) -
Psoas Abscess
por: Jefferies, Chas. A.
Publicado: (1895)